SPOTLIGHT: Judge's decision new setback for Merck


A federal judge ruled against a Merck effort to have two Vioxx cases thrown out, saying that FDA approval of a drug label doesn't free it of liability. The judge called Merck's claims of immunity "unpersuasive," dealing a setback to the giant pharma company's efforts to toss out thousands of cases involving patients who began to take Vioxx after an April, 2002 label change included risks of cardiovascular incidents. Lawyers for the plaintiffs say the label warnings were inadequate. Report

Suggested Articles

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.